Sernova Biotherapeutics Inc (FRA:PSH0)

Germany flag Germany · Delayed Price · Currency is EUR
0.0875
+0.0030 (3.55%)
At close: Feb 20, 2026
Market Cap29.43M -38.1%
Revenue (ttm)n/a
Net Income-9.74M
EPS-0.03
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,935
Average Volume3,493
Open0.0875
Previous Close0.0845
Day's Range0.0875 - 0.0875
52-Week Range0.0750 - 0.1500
Betan/a
RSI48.59
Earnings DateJan 27, 2026

About Sernova Biotherapeutics

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc ... [Read more]

Industry Biological Products, Except Diagnostic Substances
CEO Jonathan M. Rigby
Employees 8
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol PSH0
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements